Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
SEC and Kiromic settle over biotech's failure to disclose clinical trial holds ahead of stock offering
5 months ago
Law
Eli Lilly, Pfizer stress independence of telehealth partners in response to senators
5 months ago
FDA+
Coherus makes final, $483M pivot away from biosimilars
5 months ago
Deals
Takeda to pay $200M for rights to anemia drug from Keros
5 months ago
Deals
Gilead makes another ADC move, inking up to $415M pact with Tubulis
5 months ago
Startups
Deals
Roche teams up with Chicago autoimmune biotech COUR Pharmaceuticals
5 months ago
Deals
J&J looks to expand Tremfya in two pediatric indications
5 months ago
FDA+
Biocon lands FDA approval for another Stelara biosimilar
5 months ago
FDA+
Novartis pays $1B upfront for PTC's Phase 2 Huntington's drug
5 months ago
Deals
FDA is looking into hematology risks after patients take bluebird's Skysona gene therapy
6 months ago
Cell/Gene Tx
FDA+
Novartis to cut 139 jobs in NJ as part of commercial refocus
6 months ago
People
Advanz Pharma faces revocation of European authorization for liver disease drug Ocaliva
6 months ago
Bristol Myers sues the federal government over 340B, following other drugmakers
6 months ago
Law
The Biden administration wants Medicare and Medicaid to cover GLP-1s. Will the Trump White House allow it?
6 months ago
FDA+
Soleno’s rare pediatric disease drug faces PDUFA delay by three months
6 months ago
FDA+
Bristol Myers reveals more job cuts in New Jersey
6 months ago
Minnesota 340B revenue driven by hospitals and high-priced drugs, first state report says
6 months ago
Merck halts Phase 3 trial with PAH drug Winrevair following positive interim data
6 months ago
Gilead buys experimental HIV vaccines from a small Barcelona biotech
6 months ago
Startups
Deals
AstraZeneca’s Truqap edges closer to prostate cancer label expansion with Phase 3 win
6 months ago
R&D
For CDC, Trump picks Dave Weldon, a former congressman who pushed for vaccine injury claims
6 months ago
People
FDA+
FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam
6 months ago
FDA+
Sanofi introduces new 340B payment model — report
6 months ago
Law
Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders
6 months ago
Law
First page
Previous page
23
24
25
26
27
28
29
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit